Inozyme Pharma To Report Topline Data From Ongoing Phase 1/2 Trials Of INZ-701 In Adults With ABCC6 Deficiency And ENPP1 Deficiency On April 8, 2024
Inozyme Pharma To Report Topline Data From Ongoing Phase 1/2 Trials Of INZ-701 In Adults With ABCC6 Deficiency And ENPP1 Deficiency On April 8, 2024
Inozyme Pharma 将于 2024 年 4 月 8 日报告正在进行的针对缺乏 ABCC6 和 ENPP1 的成年人进行的 INZ-701 1/2 期试验的主要数据
- Company to host conference call and webcast featuring key opinion leaders on Monday, April 8, 2024 at 8:00 a.m. ET -
-公司将于美国东部时间 2024 年 4 月 8 日星期一上午 8:00 举办由主要意见领袖参加的电话会议和网络直播-